Societal CDMO's GAAP loss for 3 months of 2022 was $4.3 million, down 36.8% from $6.8 million in the previous year. Revenue increased by 26.2% to $21.2 million compared to $16.8 million a year earlier.
Societal CDMO's GAAP loss for 3 months of 2022 was $4.3 million, down 36.8% from $6.8 million in the previous year. Revenue increased by 26.2% to $21.2 million compared to $16.8 million a year earlier. 
ir.recropharma.com
English (US) 